The Congressional Record is a unique source of public documentation. It started in 1873, documenting nearly all the major and minor policies being discussed and debated.
“ADDITIONAL STATEMENTS” mentioning Richard Blumenthal was published in the Senate section on page S2443 on May 11.
Of the 100 senators in 117th Congress, 24 percent were women, and 76 percent were men, according to the Biographical Directory of the United States Congress.
Senators' salaries are historically higher than the median US income.
The publication is reproduced in full below:
ADDITIONAL STATEMENTS
______
REMEMBERING DR. SAUL HERTZ
Mr. BLUMENTHAL. Mr. President, today I rise to recognize Dr. Saul Hertz, a pioneer for medical uses of radioiodine, RAI.
The son of Jewish immigrants from Poland, Dr. Hertz graduated from Harvard Medical School in 1929. While serving as director of the Massachusetts General Hospital's thyroid unit, he attended a presentation about the use of physics in medicine. Inspired by the concept, Dr. Hertz worked alongside Massachusetts Institute of Technology physicist Dr. Arthur Roberts to discover the potential for iodine radioisotopes in thyroid disease diagnosis and treatment.
On March 31, 1941, after years of experiments, Dr. Hertz administered the first therapeutic use of radioiodine to a human patient. Never before had humans been successfully treated with an artificially produced radioactive material. In 1946, Dr. Hertz was the lead author of the May issue of the Journal of the American Medical Association, which featured a 5-year study following 29 patients he treated through this method. Today, medical uses of RAI remain the gold standard of targeted precision oncology.
Dr. Hertz made a number of other outstanding contributions to the medical field. Notably, his research played an essential role in the developing field of nuclear medicine, which was critical during World War II and beyond. In 1949, he established the first Nuclear Medicine Department at the Massachusetts Women's Hospital.
Dr. Hertz passed away on July 28, 1950, but his legacy is enduring. Not only does his work continue to support extraordinary medical work, but his memory also encourages other researchers through the Saul Hertz, MD, Award. Bestowed by the Society for Nuclear Medicine and Molecular Engineering, this eponymous award honors individuals who make phenomenal strides in the radionuclide therapy field.
Dr. Hertz's archives are kept in Greenwich, CT, offering a rich history of research in this critical field and a testament to his brilliant, lifesaving work. This year, Greenwich, CT, First Selectman Fred Camillo issued a proclamation, naming March 31 ``Dr. Saul Hertz Nuclear Medicine/Radio Pharmaceutical Day.'' This recognition is a tribute to Dr. Hertz's remarkable legacy and the impact he will forever have on this field.
I applaud his many accomplishments and hope my colleagues will join me in remembering Dr. Saul Hertz.
____________________
Alerts Sign-up